Soleno Therapeutics (SLNO) Gross Profit Growth (1y) (2016 - 2018)

Soleno Therapeutics (SLNO) Gross Profit Growth (1y) (2016 - 2018) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Profit Growth (1y) (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 41.37%
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 7.76%
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 16.94%
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 68.41%
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 Soleno Therapeutics 874.25 Mn 618.67 Mn 93.41 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2018 163.41%
Jun 30, 2017 16.33%
Mar 31, 2017 500.00%
Dec 31, 2016 504.19%
Sep 30, 2016 -136.65%
Jun 30, 2016 -165.33%
Mar 31, 2016 -450.00%